Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

Juergen Rech; Koray Tascilar; Melanie Hagen; Arnd Kleyer; Bernhard Manger; Verena Schoenau; Axel J Hueber; Stefan Kleinert; Xenofon Baraliakos; Jürgen Braun; Uta Kiltz; Martin Fleck; Andrea Rubbert-Roth; David M Kofler; Frank Behrens; Martin Feuchtenberger; Michael Zaenker; Reinhard Voll; Nils Venhoff; Jens Thiel; Cornelia Glaser; Eugen Feist; Gerd R Burmester; Kirsten Karberg; Johannes Strunk; Juan D Cañete; Ladislav Senolt; Maria Filkova; Esperanza Naredo; Raquel Largo; Gerhard Krönke; Maria Antonietta D'Agostino; Mikkel Østergaard; Georg Schett

doi:10.1016/S0140-6736(23)02650-8

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

Juergen Rech, Koray Tascilar, Melanie Hagen, Arnd Kleyer, Bernhard Manger, Verena Schoenau, Axel J Hueber, Stefan Kleinert, Xenofon Baraliakos, Jürgen Braun, Uta Kiltz, Martin Fleck, Andrea Rubbert-Roth, David M Kofler, Frank Behrens, Martin Feuchtenberger, Michael Zaenker, Reinhard Voll, Nils Venhoff, Jens ThielCornelia Glaser, Eugen Feist, Gerd R Burmester, Kirsten Karberg, Johannes Strunk, Juan D Cañete, Ladislav Senolt, Maria Filkova, Esperanza Naredo, Raquel Largo, Gerhard Krönke, Maria Antonietta D'Agostino, Mikkel Østergaard, Georg Schett

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	N/A-N/A
Journal	The Lancet
DOIs	https://doi.org/10.1016/S0140-6736(23)02650-8
Publication status	Published - 2024

Keywords

Abatacept, rheumatoid arthritis, ARIAA,

Access to Document

10.1016/S0140-6736(23)02650-8

Cite this

Rech, J., Tascilar, K., Hagen, M., Kleyer, A., Manger, B., Schoenau, V., Hueber, A. J., Kleinert, S., Baraliakos, X., Braun, J., Kiltz, U., Fleck, M., Rubbert-Roth, A., Kofler, D. M., Behrens, F., Feuchtenberger, M., Zaenker, M., Voll, R., Venhoff, N., ... Schett, G. (2024). Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. The Lancet, N/A-N/A. https://doi.org/10.1016/S0140-6736(23)02650-8

@article{ee18fd8d36284034ba45423313594a84,

title = "Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial",

keywords = "Abatacept, rheumatoid arthritis, ARIAA,, Abatacept, rheumatoid arthritis, ARIAA,",

author = "Juergen Rech and Koray Tascilar and Melanie Hagen and Arnd Kleyer and Bernhard Manger and Verena Schoenau and Hueber, {Axel J} and Stefan Kleinert and Xenofon Baraliakos and J{\"u}rgen Braun and Uta Kiltz and Martin Fleck and Andrea Rubbert-Roth and Kofler, {David M} and Frank Behrens and Martin Feuchtenberger and Michael Zaenker and Reinhard Voll and Nils Venhoff and Jens Thiel and Cornelia Glaser and Eugen Feist and Burmester, {Gerd R} and Kirsten Karberg and Johannes Strunk and Ca{\~n}ete, {Juan D} and Ladislav Senolt and Maria Filkova and Esperanza Naredo and Raquel Largo and Gerhard Kr{\"o}nke and D'Agostino, {Maria Antonietta} and Mikkel {\O}stergaard and Georg Schett",

year = "2024",

doi = "10.1016/S0140-6736(23)02650-8",

language = "English",

pages = "N/A--N/A",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

Rech, J, Tascilar, K, Hagen, M, Kleyer, A, Manger, B, Schoenau, V, Hueber, AJ, Kleinert, S, Baraliakos, X, Braun, J, Kiltz, U, Fleck, M, Rubbert-Roth, A, Kofler, DM, Behrens, F, Feuchtenberger, M, Zaenker, M, Voll, R, Venhoff, N, Thiel, J, Glaser, C, Feist, E, Burmester, GR, Karberg, K, Strunk, J, Cañete, JD, Senolt, L, Filkova, M, Naredo, E, Largo, R, Krönke, G, D'Agostino, MA, Østergaard, M & Schett, G 2024, 'Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial', The Lancet, pp. N/A-N/A. https://doi.org/10.1016/S0140-6736(23)02650-8

TY - JOUR

T1 - Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

AU - Rech, Juergen

AU - Tascilar, Koray

AU - Hagen, Melanie

AU - Kleyer, Arnd

AU - Manger, Bernhard

AU - Schoenau, Verena

AU - Hueber, Axel J

AU - Kleinert, Stefan

AU - Baraliakos, Xenofon

AU - Braun, Jürgen

AU - Kiltz, Uta

AU - Fleck, Martin

AU - Rubbert-Roth, Andrea

AU - Kofler, David M

AU - Behrens, Frank

AU - Feuchtenberger, Martin

AU - Zaenker, Michael

AU - Voll, Reinhard

AU - Venhoff, Nils

AU - Thiel, Jens

AU - Glaser, Cornelia

AU - Feist, Eugen

AU - Burmester, Gerd R

AU - Karberg, Kirsten

AU - Strunk, Johannes

AU - Cañete, Juan D

AU - Senolt, Ladislav

AU - Filkova, Maria

AU - Naredo, Esperanza

AU - Largo, Raquel

AU - Krönke, Gerhard

AU - D'Agostino, Maria Antonietta

AU - Østergaard, Mikkel

AU - Schett, Georg

PY - 2024

Y1 - 2024

KW - Abatacept, rheumatoid arthritis, ARIAA,

UR - http://hdl.handle.net/10807/262745

U2 - 10.1016/S0140-6736(23)02650-8

DO - 10.1016/S0140-6736(23)02650-8

M3 - Article

SN - 0140-6736

SP - N/A-N/A

JO - The Lancet

JF - The Lancet

ER -

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

Keywords

Access to Document

Other files and links

Cite this